Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Predicting time to recall in patients conditionally released from a secure forensic hospital: A survival analysis.

Jewell A, Cocks C, Cullen AE, Fahy T, Dean K.

Eur Psychiatry. 2018 Mar;49:1-8. doi: 10.1016/j.eurpsy.2017.11.005. Epub 2018 Jan 30.

PMID:
29353176
2.

TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer.

Ferraro D, Goldstein D, O'Connell RL, Zalcberg JR, Sjoquist KM, Tebbutt NC, Grimison P, McLachlan S, Lipton LL, Vasey P, Gebski VJ, Aiken C, Cronk M, Ng S, Karapetis CS, Shannon J; behalf of the the Australasian Gastro-Intestinal Trials Group.

Cancer Chemother Pharmacol. 2016 Aug;78(2):361-7. doi: 10.1007/s00280-016-3089-4. Epub 2016 Jun 22.

PMID:
27335026
3.

Patient outcomes following discharge from secure psychiatric hospitals: systematic review and meta-analysis.

Fazel S, Fimińska Z, Cocks C, Coid J.

Br J Psychiatry. 2016 Jan;208(1):17-25. doi: 10.1192/bjp.bp.114.149997. Review.

4.

Are manic symptoms that 'dip' into depression the essence of mixed features?

Malhi GS, Fritz K, Allwang C, Burston N, Cocks C, Devlin J, Harper M, Hoadley B, Kearney B, Klug P, Meagher L, Rowe M, Samir H, Way R, Wilson C, Lyndon W.

J Affect Disord. 2016 Mar 1;192:104-8. doi: 10.1016/j.jad.2015.12.009. Epub 2015 Dec 18.

PMID:
26717522
5.

Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke.

Mair G, von Kummer R, Morris Z, von Heijne A, Bradey N, Cala L, Peeters A, Farrall AJ, Adami A, Potter G, Cohen G, Sandercock PA, Lindley RI, Wardlaw JM; IST-3 Collaborative Group.

Neurology. 2016 Jan 12;86(2):118-25. doi: 10.1212/WNL.0000000000002236. Epub 2015 Dec 9.

6.

Agitation for recognition by DSM-5 mixed features specifier signals fatigue?

Malhi GS, Fritz K, Allwang C, Burston N, Cocks C, Harper M, Kearney B, Klug P, Meagher L, Mimnagh J, Purayil S, Rowe M, Samir H, Way R, Wilson C, Lyndon W.

Aust N Z J Psychiatry. 2015 Jun;49(6):499-501. doi: 10.1177/0004867415585858. Epub 2015 Apr 30. No abstract available.

PMID:
25931574
7.

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

IST-3 collaborative group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A.

Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23. Erratum in: Lancet. 2012 Aug 25;380(9843):730.

8.

Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study.

Ting RD, Keech AC, Drury PL, Donoghoe MW, Hedley J, Jenkins AJ, Davis TM, Lehto S, Celermajer D, Simes RJ, Rajamani K, Stanton K; FIELD Study Investigators.

Diabetes Care. 2012 Feb;35(2):218-25. doi: 10.2337/dc11-1109. Epub 2011 Dec 30.

9.

Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited.

Sandercock P, Lindley R, Wardlaw J, Dennis M, Innes K, Cohen G, Whiteley W, Perry D, Soosay V, Buchanan D, Venables G, Czlonkowska A, Kobayashi A, Berge E, Slot KB, Murray V, Peeters A, Hankey GJ, Matz K, Brainin M, Ricci S, Cantisani TA, Gubitz G, Phillips SJ, Antonio A, Correia M, Lyrer P, Kane I, Lundstrom E; IST-3 collaborative group.

Trials. 2011 Nov 30;12:252. doi: 10.1186/1745-6215-12-252.

10.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators.

Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12.

11.

Home use of automated external defibrillators for sudden cardiac arrest.

Bardy GH, Lee KL, Mark DB, Poole JE, Toff WD, Tonkin AM, Smith W, Dorian P, Packer DL, White RD, Longstreth WT Jr, Anderson J, Johnson G, Bischoff E, Yallop JJ, McNulty S, Ray LD, Clapp-Channing NE, Rosenberg Y, Schron EB; HAT Investigators.

N Engl J Med. 2008 Apr 24;358(17):1793-804. doi: 10.1056/NEJMoa0801651. Epub 2008 Apr 1.

12.

Predicting outcome in hyper-acute stroke: validation of a prognostic model in the Third International Stroke Trial (IST3).

SCOPE (Stroke Complications and Outcomes Prediction Engine) Collaborations; IST, Lewis SC, Sandercock PA, Dennis MS.

J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):397-400. Epub 2007 Aug 31.

PMID:
17766429
13.

Mediastinal teratoma: two case reports.

Cocks CE, Kamdar HH.

East Afr Med J. 1994 Jan;71(1):63-6.

PMID:
8055770

Supplemental Content

Loading ...
Support Center